Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

Clinical trial NCT05426005 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05426005
Sponsor: Sun Yat-sen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Stage IV Mismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)

Start date: 2023-02-07
Primary completion: 2026-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.